English | Español
Patient Daily | Mar 30, 2026

Rocket Pharmaceuticals receives FDA approval for gene therapy to treat rare immune disease
Patient Daily | Mar 30, 2026

Novartis announces $2 billion acquisition of Excellergy to expand immunology portfolio
Patient Daily | Mar 30, 2026

Robert Malone resigns as CDC vaccine advisory group vice chair after controversy
Patient Daily | Mar 30, 2026

Industry and academic leaders gather to accelerate new cancer cures
Patient Daily | Mar 30, 2026

FDA approves first gene therapy for rare pediatric immune disorder
Patient Daily | Mar 30, 2026

Study links diagnostic timing to ovarian cancer survival outcomes
Patient Daily | Mar 30, 2026

Study reveals how a promising bacterial therapy reduces recurrent bacterial vaginosis
Patient Daily | Mar 30, 2026

UMGCCC awarded $3 million to train the next generation of oncology researchers

Trending
+ Regulatory
Patient Daily | Mar 30, 2026

Freedom Foundation CEO Meeks on 340B: 'The program has morphed into a veritable ATM for hospitals'
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Alliance for Consumers releases update on trial law firm political donations
+ Pharmaceuticals
Patient Daily | Mar 27, 2026

Bayer asks Supreme Court to protect federal regulation from state tort litigation
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Dartmouth Cancer Center study finds blood pressure drug may boost cancer therapy